Phase 1 clinical trial of losmapimod in facioscapulohumeral dystrophy: Safety, tolerability, pharmacokinetics, and target engagement

202137 citationsJournal Articlebronze Open Access

Authors

Clinical trial identifier ToetsingOnline: NL68539.056.18 Nederlands Trials Register NL8000.

Good health and well-being

Published in: British Journal of Clinical Pharmacology

Volume 87, Issue 12, pp. 4658-4669

Field-Weighted Citation Impact: 2.57